The DOI matches its Crossref record; 330 of the 330 references it cites were found in a registry or an index.
Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions
Open accessAbstract
Although Michael acceptors display a potent and broad spectrum of bioactivity, they have largely been ignored in drug discovery because of their presumed indiscriminate reactivity. As such, a dearth of information exists relevant to the thiol reactivity of natural products and their analogues possessing this moiety. In the midst of recently approved acrylamide-containing drugs, it is clear that a good understanding of the hetero-Michael addition reaction and the relative reactivities of biological thiols with Michael acceptors under physiological conditions is needed for the design and use of these compounds as biological tools and potential therapeutics. This Perspective provides information that will contribute to this understanding, such as kinetics of thiol addition reactions, bioactivities, as well as steric and electronic factors that influence the electrophilicity and reversibility of Michael acceptors. This Perspective is focused on α,β-unsaturated carbonyls given their preponderance in bioactive natural products.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Preliminary clinical studies have shown that osimertinib is capable of inhibiting the L858R mutant of EGFR up to 12 nM, and the IC50 of L858R/T790M mutant was 1 nM.”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [132]
In the citing paper
“The inhibition rate of osimertinib against EGFRL858R/T790M mutant was approximately 200-fold higher than that of the wild type.132”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [132]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pearson, R. G. (1963) · Journal of the American Chemical Society · doi:10.1021/ja00905a001 · Cited by 10,475
Absolute hardness: companion parameter to absolute electronegativity
Parr, R. G., & Pearson, R. G. (1983) · Journal of the American Chemical Society · doi:10.1021/ja00364a005 · Cited by 7,998
Parr, R. G., von Szentpály, L., & Liu, S. (1999) · Journal of the American Chemical Society · doi:10.1021/ja983494x · Cited by 7,564
Baell, J. B., & Holloway, G. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901137j · Cited by 4,196
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
Density functional approach to the frontier-electron theory of chemical reactivity
Parr, R. G., & Yang, W. (1984) · Journal of the American Chemical Society · doi:10.1021/ja00326a036 · Cited by 3,672
Hard and soft acids and bases, HSAB, part 1: Fundamental principles
Pearson, R. G. (1968) · Journal of Chemical Education · doi:10.1021/ed045p581 · Cited by 2,566
Cross, D. A. E., Ashton, S. E., Ghiorghiu, S., Eberlein, C., Nebhan, C. A., Spitzler, P. J., Orme, J. P., Finlay, M. R. V., Ward, R. A., Mellor, M. J., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0337 · Cited by 2,246
The resurgence of covalent drugs
Singh, J., Petter, R. C., Baillie, T. A., & Whitty, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3410 · Cited by 1,873
Prodrugs: design and clinical applications
Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D.-M., Järvinen, T., & Savolainen, J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2468 · Cited by 1,681
Research works printed but not linked: 6
- Parsons Z. D., 2013, Methods in Enzymology Vol. 528: Hydrogen Peroxide and Cell Signaling Part C, 528, 130
- 2014, FDA Approves Imbruvica to Treat Chronic Lymphocytic Leukemia
- gNodwell, M. B.; Sieber, S. A.Activity-Based Protein Profiling.Springer-Verlag:Berlin, 2012; Vol.324, p165;
- Atsmon J., 1990, Cancer Res., 50, 1879
- Cavalieri E., 2004, Methods in Enzymology, 382, 293
- Geroni C., 2002, Cancer Res., 62, 2332
Cited by
Sorted by citations
Items 101–200 of 618
Wang, L., Zhao, J., Yao, Y., Wang, C., Zhang, J., Shu, X. H., Sun, X., Li, Y., Liu, K., Yuan, H., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.09.024 · Cited by 39
Murakami, Y., KAWATA, A., Suzuki, S., & Fujisawa, S. (2018) · In Vivo · doi:10.21873/invivo.11381 · Cited by 39
Dar’in, D. V., Kantin, G. P., Bakulina, O., Inyutina, A., Chupakhin, E. G., & Krasavin, M. (2020) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.0c02356 · Cited by 39
Lou, J., Lu, Y., Cheng, J., Zhou, F., Yan, Z., Zhang, D., Meng, X., & Zhao, Y. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114684 · Cited by 39
Hou, W., Zhang, G., Luo, Z., Li, D., Ruan, H., Ruan, B. H., Su, L., & Xu, H. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.11.014 · Cited by 38
Lauzon, S., Keipour, H., Gandon, V., & Ollevier, T. (2017) · Organic Letters · doi:10.1021/acs.orglett.7b03118 · Cited by 38
Sansalone, L., Véliz, E. A., Myrthil, N. G., Stathias, V., Walters, W. M., Torrens, I., Schürer, S. C., Vanni, S., Leblanc, R. M., & Graham, R. M. (2019) · Cancers · doi:10.3390/cancers11030357 · Cited by 37
Sun, J., Zhong, H., Wang, K., Li, N., & Chen, L. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.02.023 · Cited by 39
Awoonor‐Williams, E., & Rowley, C. N. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00897 · Cited by 37
Chemical inhibition of mitochondrial fission via targeting the DRP1-receptor interaction
Yang, J., Chen, P., Cao, Y., Liu, S., Wang, W., Li, L., Li, J., Jiang, Z., Ma, Y., Chen, S., et al. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.02.002 · Cited by 36
Tideglusib and Its Analogues As Inhibitors of Staphylococcus aureus SrtA
Yang, T. K., Zhang, T., Guan, X., Dong, Z., Lan, L., Yang, S., & Yang, C. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00803 · Cited by 36
Parthenolide Destabilizes Microtubules by Covalently Modifying Tubulin
Hotta, T., Haynes, S. E., Blasius, T. L., Gebbie, M., Eberhardt, E. L., Sept, D., Cianfrocco, M. A., Verhey, K. J., Nesvizhskii, A. I., & Ohi, R. (2020) · Current Biology · doi:10.1016/j.cub.2020.11.055 · Cited by 36
Late‐Stage C−H Activation of Drug (Derivative) Molecules with Pd(ll) Catalysis
Shim, S. Y. (2023) · Chemistry - A European Journal · doi:10.1002/chem.202302620 · Cited by 35
Lakshmi, S. P., Reddy, A. T., Banno, A., & Reddy, R. C. (2019) · Biochemical Journal · doi:10.1042/bcj20190253 · Cited by 35
Andrés, C. M. C., de la Lastra, J. M. P., Munguira, E. B., Andrés, C., Plou, F. J., & Lebeña, E. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063521 · Cited by 34
Mahalapbutr, P., Wonganan, P., Chavasiri, W., & Rungrotmongkol, T. (2019) · Cancers · doi:10.3390/cancers11040437 · Cited by 34
Alves, N. G., Bártolo, I., Alves, A. J. S., Fontinha, D., Francisco, D., Lopes, S. M. M., Soares, M. I. L., Simões, C. J. V., Prudêncio, M., Taveira, N., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113439 · Cited by 34
Covalent chemical probes for protein kinases
Serafim, R. A. M., Haarer, L., Pedreira, J. G. B., & Gehringer, M. (2023) · Current Research in Chemical Biology · doi:10.1016/j.crchbi.2022.100040 · Cited by 34
Aboukhatwa, S. M., Sidhom, P. A., Angeli, A., Supuran, C. T., & Tawfik, H. O. (2023) · ACS Omega · doi:10.1021/acsomega.2c07285 · Cited by 34
Wu, X., Dai, M., Cui, R., Wang, Y., Li, C., Xia, P., Zhao, J., Wang, B., Dai, Y., Feng, D., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.09.002 · Cited by 33
N-Terminal cysteine mediated backbone-side chain cyclization for chemically enhanced phage display
Zheng, M., Hæffner, F., & Gao, J. (2022) · Chemical Science · doi:10.1039/d2sc03241d · Cited by 33
Mechanistic aspects of thiol additions to Michael acceptors: Insights from computations
Roseli, R. B., Keto, A. B., & Krenske, E. H. (2022) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1636 · Cited by 32
Chen, D., Guo, D., Yan, Z., & Zhao, Y. (2017) · MedChemComm · doi:10.1039/c7md00571g · Cited by 32
Covalent allosteric modulation: An emerging strategy for GPCRs drug discovery
Bian, Y., Jun, J. J., Cuyler, J., & Xie, X. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112690 · Cited by 31
Morris, G., Gamage, E., Travica, N., Berk, M., Jacka, F. N., O'Neil, A. E., Puri, B. K., Carvalho, A. F., Bortolasci, C. C., Walder, K. R., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.036 · Cited by 31
Jervis, P. J., Amorim, C., Pereira, T., Martins, J. A., & Ferreira, P. M. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052528 · Cited by 31
Bálint, D., Póti, Á. L., Alexa, A., Sok, P., Albert, K., Torda, L., Földesi-Nagy, D., Csókás, D., Turczel, G., Imre, T., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52573-2 · Cited by 30
Photopolymerized Starchstarch Nanoparticle (SNP) network hydrogels
Majcher, M. J., McInnis, C. L., Himbert, S., Alsop, R. J., Kinio, D., Bleuel, M., Rheinstadter, M. C., Smeets, N. M. B., & Hoare, T. R. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.115998 · Cited by 30
Hu, Y., Tang, L., Zhu, Z., Meng, H., Chen, T., Zhao, S., Jin, Z., Wang, Z., & Jin, G. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02275-2 · Cited by 30
Takei, D., Yatabe, T., Jin, X., Yabe, T., Mizuno, N., & Yamaguchi, K. (2020) · ACS Catalysis · doi:10.1021/acscatal.0c00277 · Cited by 30
Targeting eukaryotic proteases for natural products-based drug development
Al‐Awadhi, F. H., & Luesch, H. (2020) · Natural Product Reports · doi:10.1039/c9np00060g · Cited by 30
Chakraborty, S., Mallick, D., Goswami, M., Guengerich, F. P., Chakrabarty, A., & Chowdhury, G. (2022) · Journal of Natural Products · doi:10.1021/acs.jnatprod.2c00521 · Cited by 30
Covalent hits and where to find them
Lucas, S. C. C., Blackwell, J. H., Hewitt, S. H., Semple, H., Whitehurst, B. C., & Xu, H. (2024) · SLAS DISCOVERY · doi:10.1016/j.slasd.2024.01.003 · Cited by 30
Hammer, N., Erickson, J. D., Lauridsen, V. H., Jakobsen, J. B., Hansen, B. K., Jacobsen, K. M., Poulsen, T. B., & Jørgensen, K. A. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201808221 · Cited by 29
Truax, N. J., Ayinde, S., Van, K. N., Liu, J. O., & Romo, D. (2019) · Organic Letters · doi:10.1021/acs.orglett.9b02713 · Cited by 29
Targeted Covalent Inhibition of Telomerase
Betori, R. C., Liu, Y., Wu, D., Mishra, R., Cohen, S., Kron, S. J., & Scheidt, K. A. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.9b00945 · Cited by 29
Andrés, C. M. C., Lobo, F., de la Lastra, J. M. P., Munguira, E. B., Andrés, C., & Lebeña, E. P. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47090765 · Cited by 28
Parkinson, E., Aleksić, M., Cubberley, R., Kaur‐Atwal, G., Vissers, J. P. C., & Skipp, P. J. S. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx265 · Cited by 28
Spiralyde A, an Antikinetoplastid Dolabellane from the Brown Alga Dictyota spiralis
Chiboub, O., Sifaoui, I., Lorenzo‐Morales, J., Abderrabba, M., Mejri, M., Fernández, J. J., Piñero, J. E., & Díaz‐Marrero, A. R. (2019) · Marine Drugs · doi:10.3390/md17030192 · Cited by 28
Kang, M. S., Khoo, Y. X. J., Jia, Z., & Loh, T. (2022) · Green Synthesis and Catalysis · doi:10.1016/j.gresc.2022.09.002 · Cited by 28
Prasse, C. (2021) · Environmental Science Processes & Impacts · doi:10.1039/d0em00471e · Cited by 28
Into the Fray! A Beginner's Guide to Medicinal Chemistry
Veale, C. G. L. (2021) · ChemMedChem · doi:10.1002/cmdc.202000929 · Cited by 28
Wodtke, R., Wodtke, J., Hauser, S., Laube, M., Bauer, D., Rothe, R., Neuber, C., Pietsch, M., Kopka, K., Pietzsch, J., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00096 · Cited by 27
Sulfur in Dynamic Covalent Chemistry
Orrillo, A. G., & Furlán, R. L. E. (2022) · Angewandte Chemie · doi:10.1002/ange.202201168 · Cited by 27
Citarella, A., Moi, D., Pedrini, M., Pérez‐Peña, H., Pieraccini, S., Dimasi, A., Stagno, C., Micale, N., Schirmeister, T., Sibille, G., et al. (2023) · Organic & Biomolecular Chemistry · doi:10.1039/d3ob00381g · Cited by 27
Pharmacological property optimization for allosteric ligands: A medicinal chemistry perspective
Johnstone, S., & Albert, J. S. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.03.084 · Cited by 27
Synthesis of Acrylamides via the Doebner–Knoevenagel Condensation
Zacuto, M. J. (2019) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.9b00450 · Cited by 27
Synthesis and antimicrobial evaluation of new halogenated 1,3-Thiazolidin-4-ones
Hammad, S. G., El-Gazzar, M. G., Abutaleb, N. S., Li, D., Ramming, I., Shekhar, A., Abdel‐Halim, M., Elrazaz, E. Z., Seleem, M. N., Bilitewski, U., et al. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103517 · Cited by 27
Tran, Q. T. N., Tan, D. W. S., Wong, W. S. F., & Chai, C. L. L. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112481 · Cited by 26
Serrano-Sterling, C., Becerra, D., Portilla, J., Rojas, H. A., Macias, M. A., & Castillo, J. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.130944 · Cited by 26
Manganese(I) Catalyzed α-Alkenylation of Amides Using Alcohols with Liberation of Hydrogen and Water
Pandia, B. K., & Gunanathan, C. (2021) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.1c00685 · Cited by 26
Discovery of Novel Celastrol–Imidazole Derivatives with Anticancer Activity In Vitro and In Vivo
Li, N., Xu, M., Zhang, L., Lei, Z., Chen, C., Zhang, T., Chen, L., & Sun, J. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01293 · Cited by 26
Shawky, A. M., Almalki, F. A., Alzahrani, H. A., Abdalla, A. N., Youssif, B. G. M., Ibrahim, N. A., Gamal, M., El-Sherief, H. A. M., Abdel‐Fattah, M. M., Hefny, A. A., et al. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116704 · Cited by 26
Rajeshkumar, V., Neelamegam, C., & Anandan, S. (2019) · Organic & Biomolecular Chemistry · doi:10.1039/c8ob03051k · Cited by 26
Anticancer properties of 5Z-(4-fluorobenzylidene)-2-(4-hydroxyphenylamino)-thiazol-4-one
Szychowski, K. A., Kaminskyy, D. V., Leja, M. L., Kryshchyshyn‐Dylevych, A., Lesyk, R., Tobiasz, J., Wnuk, M., Pomianek, T., & Gmiński, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-47177-6 · Cited by 26
Elnaas, A. R., Grice, I. D., Han, J., Feng, Y., Capua, A. D., Mak, T., Laureanti, J. A., Buchko, G. W., Myler, P. J., Cook, G. M., et al. (2020) · Molecules · doi:10.3390/molecules25102384 · Cited by 26
Pativada, T., Kim, M. H., Lee, J.-H., Hong, S. S., Choi, C. W., Choi, Y., Kim, W. J., Song, D.-W., Park, S. I., Lee, E. J., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00270 · Cited by 25
Targeted Covalent Inhibition of Plasmodium FK506 Binding Protein 35
Atack, T. C., Raymond, D. D., Blomquist, C., Pasaje, C. F. A., McCarren, P. R., Moroco, J. A., Befekadu, H. B., Robinson, F. P., Pal, D., Esherick, L. Y., et al. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00272 · Cited by 25
Exploration of BAY 11-7082 as a Potential Antibiotic
Coles, V. E., Darveau, P., Zhang, X., Harvey, H., Henriksbo, B. D., Yang, A., Schertzer, J. D., Magolan, J., & Burrows, L. L. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00522 · Cited by 25
Widen, J. C., Kempema, A., Baur, J. W., Skopec, H. M., Edwards, J. T., Brown, T. J., Brown, D. A., Meece, F. A., & Harki, D. A. (2018) · ChemMedChem · doi:10.1002/cmdc.201700752 · Cited by 25
Self-citationZhang, X., Liu, Z., Sun, B., Niu, S., Wang, M.-H., Tan, X., Zou, Z.-M., & Ding, G. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b02648 · Cited by 25
The McKenna reaction – avoiding side reactions in phosphonate deprotection
Justyna, K., Małolepsza, J., Kusy, D., Maniukiewicz, W., & Błażewska, K. M. (2020) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.16.119 · Cited by 25
Kenari, F., Molnár, S., & Perjési, P. (2021) · Molecules · doi:10.3390/molecules26144332 · Cited by 25
Activatable covalent labeling probes: design, mechanism, and biological applications
Miao, Y., Tian, Y., & Ye, D. (2025) · Chemical Society Reviews · doi:10.1039/d5cs00984g · Cited by 24
Huang, Y., Wei, L., Han, X., Chen, H., Ren, Y., Xu, Y., Song, R., Rao, L., Chen, S., Peng, C., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111749 · Cited by 24
Itaconic acid hybrids as potential anticancer agents
Perković, I., Beus, M., Schols, D., Persoons, L., & Zorc, B. (2020) · Molecular Diversity · doi:10.1007/s11030-020-10147-6 · Cited by 24
Chemistry and biology of enzymes in protein glutathionylation
Oppong, D., Schiff, W., Shivamadhu, M. C., & Ahn, Y. (2023) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2023.102326 · Cited by 24
Covalent Kinase Inhibitors: An Overview
Gehringer, M. (2020) · Topics in medicinal chemistry · doi:10.1007/7355_2020_103 · Cited by 24
Shchegravina, E. S., Svirshchevskaya, E. V., Combes, S., Allegro, D., Barbier, P., Gigant, B., Varela, P. F., Gavryushin, A. E., Kobanova, D. A., Shchekotikhin, A. E., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112724 · Cited by 24
Electrophilic Natural Products as Drug Discovery Tools
Gehrtz, P., & London, N. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.03.008 · Cited by 25
Dai, W., Samanta, S., Xue, D., Petrunak, E. M., Stuckey, J. A., Han, Y., Sun, D., Wu, Y., & Neamati, N. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01960 · Cited by 24
Mancuso, R., Ziccarelli, I., Brindisi, M., Altomare, C., Frattaruolo, L., Falcicchio, A., Ca’, N. D., Cappello, A. R., & Gabriele, B. (2021) · Catalysts · doi:10.3390/catal11020227 · Cited by 23
Nucleophilic Reactivities of Thiophenolates
Jüstel, P. M., Pignot, C. D., & Ofial, A. R. (2021) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.1c00025 · Cited by 23
Wu, Z., & Dong, G. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202201239 · Cited by 23
Maitra, U., Conger, J., Owens, M. M., & Ciesla, L. M. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2023.02.008 · Cited by 23
Synthesis of Diverse N-Acryloyl Azetidines and Evaluation of Their Enhanced Thiol Reactivities
Palkowitz, M. D., Tan, B., Hu, H., Roth, K. D. W., & Bauer, R. A. (2017) · Organic Letters · doi:10.1021/acs.orglett.7b00788 · Cited by 23
Freund, R. R. A., Gobrecht, P., Rao, Z., Gerstmeier, J., Schlosser, R., Görls, H., Werz, O., Fischer, D., & Arndt, H. (2019) · Chemical Science · doi:10.1039/c9sc01473j · Cited by 23
A Simple Protocol for the Stereoselective Construction of Enaminyl Sulfonyl Fluorides
Leng, J., Tang, W., Fang, W., Zhao, C., & Qin, H. (2020) · Organic Letters · doi:10.1021/acs.orglett.0c01360 · Cited by 23
Protocol for Stereoselective Construction of Highly Functionalized Dienyl Sulfonyl Fluoride Warheads
Zhang, Z.-W., Wang, S., Fang, W., Lekkala, R., & Qin, H. (2020) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.0c01877 · Cited by 23
Boyko, Y. D., Huck, C. J., Ning, S., Shved, A. S., Yang, C., Chu, T., Tonogai, E. J., Hergenrother, P. J., & Šarlah, D. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.0c12569 · Cited by 23
Discovery of Irreversible p97 Inhibitors
Ding, R., Zhang, T., Wilson, D. J., Xie, J., Williams, J. M., Xu, Y., Ye, Y., & Chen, L. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00144 · Cited by 22
Ji, J., Sajjad, F., You, Q., Xing, D., Fan, H., Reddy, A. G. K., Hu, W., & Dong, S. (2020) · Archiv der Pharmazie · doi:10.1002/ardp.202000136 · Cited by 22
Orally effective FDA-approved protein kinase targeted covalent inhibitors (TCIs): A 2025 update
Roskoski, R. J. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107805 · Cited by 21
Sroor, F. M., Mohamed, M. F., Abdullah, G. K., Mahrous, K. F., Zoheir, K. M. A., Ibrahim, S., Elwahy, A. H. M., & Abdelhamid, I. A. (2022) · Polycyclic aromatic compounds · doi:10.1080/10406638.2022.2046616 · Cited by 21
Site-Specific Albumin-Selective Ligation to Human Serum Albumin under Physiological Conditions
Yu, X., Ruan, M., Wang, Y., Nguyen, A. D., Xiao, W., Ajena, Y., Solano, L. N., Liu, R., & Lam, K. S. (2022) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.2c00361 · Cited by 21
Evaluation of a Covalent Library of Diverse Warheads (CovLib) Binding to JNK3, USP7, or p53
Klett, T., Schwer, M., Ernst, L. N., Engelhardt, M. U., Jaag, S., Masberg, B., Knappe, C., Lämmerhofer, M., Gehringer, M., & Boeckler, F. M. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s466829 · Cited by 21
Concise Total Syntheses of ( − )-Crinipellins A and B Enabled by a Controlled Cargill Rearrangement
Xu, B., Zhang, Z., Tantillo, D. J., & Dai, M. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c07900 · Cited by 21
Chemoselective Synthesis of N-Terminal Cysteinyl Thioesters via β,γ-C,S Thiol-Michael Addition
Petracca, R., Bowen, K., McSweeney, L., O’Flaherty, S., Genna, V., Twamley, B., Devocelle, M. C., & Scanlan, E. M. (2019) · Organic Letters · doi:10.1021/acs.orglett.9b01013 · Cited by 21
Pan, L., Nie, L., Yao, S., Bi, A., Ye, Y., Wu, Y., Tan, Z. W., & Wu, Z. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4745 · Cited by 21
Jackson, P. A., Schares, H. A. M., Jones, K. F. M., Widen, J. C., Dempe, D. P., Grillet, F., Cuellar, M. E., Walters, M. A., Harki, D. A., & Brummond, K. M. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01464 · Cited by 21
Self-citationPasquer, Q. T. L., Tsakoumagkos, I. A., & Hoogendoorn, S. (2020) · Molecules · doi:10.3390/molecules25235702 · Cited by 21
Costa, A. M., Bosch, L., Petit, E., & Vilarrasa, J. (2021) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.1c00349 · Cited by 21
Recruitment of chalcone's potential in drug discovery of a nti‐SARS‐CoV ‐2 agents
Valipour, M. (2022) · Phytotherapy Research · doi:10.1002/ptr.7651 · Cited by 21
Wen, W., Cao, H., Xu, Y., Ren, Y., Rao, L., Shao, X., Chen, H., Wu, L., Liu, J., Chen, S., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00336 · Cited by 20
de Souza, B. G., Choudhary, S., Vilela, G. G., Passos, G. F. S., Costa, C. A. C. B., de Freitas, J. D., Coelho, G. L., Brandão, J. D. A., Anderson, L., Bassi, Ê. J., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115572 · Cited by 20
Huang, Y., Wang, S., Leng, J., Moku, B., Zhao, C., Alharbi, N. S., & Qin, H. (2019) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201900799 · Cited by 20
Drug repurposing for schistosomiasis: molecular docking and dynamics investigations
Ezebuo, F. C., & Uzochukwu, I. C. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1820382 · Cited by 20
Rational Design of Original Fused-Cycle Selective Inhibitors of Tryptophan 2,3-Dioxygenase
Kozlova, A., Thabault, L., Liberelle, M., Klaessens, S., Prévost, J. R. C., Mathieu, C., Pilotte, L., Stroobant, V., den Eynde, B. J. V., & Frédérick, R. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00323 · Cited by 20
Johnson, J. W., Ellis, M. J., Piquette, Z. A., MacNair, C. R., Carfrae, L. A., Bhando, T., Ritchie, N. E., Saliba, P., Brown, E. D., & Magolan, J. (2022) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.1c00648 · Cited by 20
Koszelewski, D., Borys, F., Brodzka, A., & Ostaszewski, R. (2018) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201801819 · Cited by 20
Metadata
- Authors
- Jackson, P. A., Widen, J. C., Harki, D. A., & Brummond, K. M.
- Affiliations
- University of Pittsburgh (US)
- University of Minnesota (US)
- Corresponding author
- Harki, Daniel A.
- Brummond, Kay M.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-12-20
- Volume
- 60
- Issue
- 3
- Pages
- 839-885
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- PMC
- PMC5308545
- OpenAlex
- W2564708666
- Cited by
- 588
- References
- 329
- Citations by year
- 2026: 88 · 2025: 71 · 2024: 80 · 2023: 51 · 2022: 58 · 2021: 74 · 2020: 72 · 2019: 51 · 2018: 27 · 2017: 15
- FWCI
- 14.54
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (R01-GM054161, R01-GM110129)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Physical Organic Chemistry and Reaction Kinetics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Sulfur Compounds in Biology
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and Reactivity of Sulfur-Containing Compounds
- Keywords
- α,β-unsaturated carbonyl compounds, Michael acceptors, hetero-Michael addition, thiol reactivity, acrylamide, electrophilicity, reaction kinetics, steric and electronic effects, natural products, drug design, biological activity
- MeSH terms
- Humans, Ketones, Sulfhydryl Compounds, Drug Design, Cell Line, Tumor, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review